164 related articles for article (PubMed ID: 35765923)
1. Proposed Risk Stratification and Patterns of Radioactive Iodine Therapy in Malignant Struma Ovarii.
Egan C; Stefanova D; Thiesmeyer JW; Lee YJ; Greenberg J; Beninato T; Zarnegar R; Christos PJ; Klein IL; Fahey TJ; Finnerty BM
Thyroid; 2022 Sep; 32(9):1101-1108. PubMed ID: 35765923
[No Abstract] [Full Text] [Related]
2. Optimal surgical management of well-differentiated thyroid cancer arising in struma ovarii: a series of 4 patients and a review of 53 reported cases.
Marti JL; Clark VE; Harper H; Chhieng DC; Sosa JA; Roman SA
Thyroid; 2012 Apr; 22(4):400-6. PubMed ID: 22181336
[TBL] [Abstract][Full Text] [Related]
3. Malignant struma ovarii: a population-level analysis of a large series of 68 patients.
Goffredo P; Sawka AM; Pura J; Adam MA; Roman SA; Sosa JA
Thyroid; 2015 Feb; 25(2):211-5. PubMed ID: 25375817
[TBL] [Abstract][Full Text] [Related]
4. The lack of consensus in management of malignant struma ovarii.
González Aguilera B; Guerrero Vázquez R; Gros Herguido N; Sánchez Gallego F; Navarro González E
Gynecol Endocrinol; 2015 Apr; 31(4):258-9. PubMed ID: 25539066
[TBL] [Abstract][Full Text] [Related]
5. Metastatic malignant struma ovarii to the pituitary presenting as a sellar mass and responding to total thyroidectomy with adjuvant radioactive iodine therapy.
Dissanayake A; Liu AY; Gooderham PA; MacKenzie-Feder J
BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38834312
[TBL] [Abstract][Full Text] [Related]
6. Presentation and treatment of two cases of malignant struma ovarii.
Obeidat RA; Alshwayyat S; Alshwayyat TA; Rjoop A; Sharqiah QM
BMC Womens Health; 2024 Mar; 24(1):158. PubMed ID: 38443937
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of malignant struma ovarii and cervical papillary thyroid carcinoma.
Leong A; Roche PJ; Paliouras M; Rochon L; Trifiro M; Tamilia M
J Clin Endocrinol Metab; 2013 Dec; 98(12):4599-605. PubMed ID: 24217901
[TBL] [Abstract][Full Text] [Related]
8. Papillary thyroid cancer in a struma ovarii: a report of a rare case.
Monti E; Mortara L; Zupo S; Dono M; Minuto F; Truini M; Naseri M; Giusti M
Hormones (Athens); 2015; 14(1):154-9. PubMed ID: 25402391
[TBL] [Abstract][Full Text] [Related]
9. Struma ovarii maligna.
Matysiak-Grzes M; Fischbach J; Gut P; Klimowicz A; Gryczynska M; Wasko R; Ruchala M
Neuro Endocrinol Lett; 2013; 34(2):97-101. PubMed ID: 23645304
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and survival outcomes of malignant struma ovarii confined to the ovary.
Li S; Yang T; Xiang Y; Li X; Zhang L; Deng S
BMC Cancer; 2021 Apr; 21(1):383. PubMed ID: 33836675
[TBL] [Abstract][Full Text] [Related]
11. Management of malignant struma ovarii: is aggressive therapy justified? Case report and literature review.
Leuștean L; Ungureanu MC; Preda C; Bilha SC; Obrocea F; Dănilă R; Stătescu L; Apostol Ciobanu DG
Thyroid Res; 2022 Aug; 15(1):14. PubMed ID: 35948940
[TBL] [Abstract][Full Text] [Related]
12. Radioactive iodine in differentiated thyroid cancer: a national database perspective.
Orosco RK; Hussain T; Noel JE; Chang DC; Dosiou C; Mittra E; Divi V; Orloff LA
Endocr Relat Cancer; 2019 Oct; 26(10):795-802. PubMed ID: 31443087
[TBL] [Abstract][Full Text] [Related]
13. Missed Initial Diagnosis of Malignant Struma Ovarii Containing Follicular Thyroid Carcinoma: Metastatic Pulmonary Recurrence 17 yr After Ovariectomy.
Cong H; Li T; Chen G; Liang Z; Liang J; Lin Y
Int J Gynecol Pathol; 2015 Sep; 34(5):445-9. PubMed ID: 26262453
[TBL] [Abstract][Full Text] [Related]
14. Malignant struma ovarii: From case to analysis.
Ayhan S; Kilic F; Ersak B; Aytekin O; Akar S; Turkmen O; Akgul G; Toyran A; Turan T; Kimyon Comert G
J Obstet Gynaecol Res; 2021 Sep; 47(9):3339-3351. PubMed ID: 34219334
[TBL] [Abstract][Full Text] [Related]
15. Synchronous thyroid cancer and malignant struma ovarii: concordant mutations and microRNA profile, discordant loss of heterozygosity loci.
Seo GT; Minkowitz J; Kapustin DA; Fan J; Minkowitz G; Minkowitz M; Dowling E; Matloob A; Asti D; Dhar M; Shutty C; Brickman A; Urken ML; Brandwein-Weber M; Finkelstein SD
Diagn Pathol; 2023 Apr; 18(1):47. PubMed ID: 37072862
[TBL] [Abstract][Full Text] [Related]
16. TIMING OF RADIOACTIVE IODINE THERAPY DOES NOT IMPACT OVERALL SURVIVAL IN HIGH-RISK PAPILLARY THYROID CARCINOMA.
Suman P; Wang CH; Abadin SS; Block R; Raghavan V; Moo-Young TA; Prinz RA; Winchester DJ
Endocr Pract; 2016 Jul; 22(7):822-31. PubMed ID: 27018620
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy with iodine-131 in recurrent malignant struma ovarii.
Brenner W; Bohuslavizki KH; Wolf H; Sippel C; Clausen M; Henze E
Eur J Nucl Med; 1996 Jan; 23(1):91-4. PubMed ID: 8586108
[TBL] [Abstract][Full Text] [Related]
18. Papillary thyroid carcinoma in Struma Ovarii.
Khatchapuridze K; Kekelidze N; Tsitsishvili Z; Mchedlishvili M; Kordzaia D
Gynecol Endocrinol; 2020 Aug; 36(8):749-752. PubMed ID: 32041443
[TBL] [Abstract][Full Text] [Related]
19. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
[TBL] [Abstract][Full Text] [Related]
20. Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy.
DeSimone CP; Lele SM; Modesitt SC
Gynecol Oncol; 2003 Jun; 89(3):543-8. PubMed ID: 12798728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
